Skip to main content
SpringerLink
Log in

Uremic toxins and the brain in chronic kidney disease

  • Points of View
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Chronic kidney disease (CKD) patients have an increased risk for cognitive impairment compared to the general population. The risk is much higher in CKD patients who progress to end-stage kidney disease (ESKD) and require hemodialysis or peritoneal dialysis. Multiple factors may contribute to cognitive impairment in CKD patients and in patients on chronic dialysis. However, the observation that, after kidney transplantation, there is an improvement in several cognitive performance markers and that some structural and functional brain abnormalities may improve suggests that cognitive deficits in patients on dialysis may be at least partially reversible. Recent evidence supports the hypothesis that uremic toxins may disrupt the blood brain barrier and damage the brain cells. Such brain toxicity should prompt efforts to lower the burden of uremic toxins through dialytic and non-dialytic strategies.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Drew DA, Weiner DE, Sarnak MJ (2019) Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis 74(6):782–790. https://doi.org/10.1053/j.ajkd.2019.05.017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL (2006) Cognitive impairment in hemodialysis patients is common. Neurology 67(2):216–223. https://doi.org/10.1212/01.wnl.0000225182.15532.40

    Article  CAS  PubMed  Google Scholar 

  3. Murray AM (2008) Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 15(2):123–132. https://doi.org/10.1053/j.ackd.2008.01.010

    Article  PubMed  PubMed Central  Google Scholar 

  4. van Sandwijk MS, Ten Berge IJM, Caan MWA, Düring M, van Gool WA, Majoie CBLM, Mutsaerts HMM, Schmand BA, Schrantee A, de Sonneville LMJ, Bemelman FJ (2020) Cognitive improvement after kidney transplantation is associated with structural and functional changes on MRI. Transplant Direct 6(3):e531. https://doi.org/10.1097/TXD.0000000000000976

    Article  PubMed  PubMed Central  Google Scholar 

  5. De Deyn PP et al (1995) Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27:227–237. https://doi.org/10.1016/0197-0186(95)00041-6

    Article  PubMed  Google Scholar 

  6. De Deyn PP, Vanholder R, Eloot S, Glorieux G (2009) Guanidino compounds as uremic (neuro)toxins. Semin Dial 22(4):340–345. https://doi.org/10.1111/j.1525-139X.2009.00577.x

    Article  PubMed  Google Scholar 

  7. Bobot M, Thomas L, Moyon A, Fernandez S, McKay N, Balasse L, Garrigue P, Brige P, Chopinet S, Poitevin S, Cérini C, Brunet P, Dignat-George F, Burtey S, Guillet B, Hache G (2020) Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol 31(7):1509–1521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mazumder MK, Giri A, Kumar S, Borah A (2016) A highly reproducible mice model of chronic kidney disease: evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci 161:27–36. https://doi.org/10.1016/j.lfs.2016.07.020

    Article  CAS  PubMed  Google Scholar 

  9. Jing W, Jabbari B, Vaziri ND (2018) Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res 10(7):2137–2147

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hernandez L, Ward LJ, Arefin S, Ebert T, Laucyte-Cibulskiene A; GOING-FWD Collaborators; Heimbürger O, Barany P, Wennberg L, Stenvinkel P, Kublickiene K (2022) Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci Rep 12(1):4414. https://doi.org/10.1038/s41598-022-08387-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel) 13(2):142. https://doi.org/10.3390/toxins13020142

    Article  CAS  PubMed  Google Scholar 

  12. Hernandez L, Ward LJ, Arefin S, Barany P, Wennberg L, Söderberg M, Bruno S, Cantaluppi V, Stenvinkel P, Kublickiene K (2023) Blood-brain barrier biomarkers before and after kidney transplantation. Int J Mol Sci 24(7):6628. https://doi.org/10.3390/ijms2407662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Natale G, Calabrese V, Marino G, Campanelli F, Urciuolo F, de Iure A, Ghiglieri V, Calabresi P, Bossola M, Picconi B (2021) Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease. Cell Death Discov 7(1):295. https://doi.org/10.1038/s41420-021-00685-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. D’Hooge R, De Deyn PP, Van de Vijver G, Antoons G, Raes A, Van Bogaert PP (1999) Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones. Neurosci Lett 265(2):83–86. https://doi.org/10.1016/s0304-3940(99)00190-1

    Article  Google Scholar 

  15. Yu YH, Kim SW, Im H, Oh SW, Cho NJ, Park S, Park DK, Kim DS, Gil HW (2022) Cognitive sequelae and hippocampal dysfunction in chronic kidney disease following 5/6 nephrectomy. Brain Sci 12(7):905. https://doi.org/10.3390/brainsci12070905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Karbowska M, Hermanowicz JM, Tankiewicz-Kwedlo A, Kalaska B, Kaminski TW, Nosek K, Wisniewska RJ, Pawlak D (2020) Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model. Sci Rep 10(1):9483. https://doi.org/10.1038/s41598-020-66421-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Watanabe K, Sato E, Mishima E, Watanabe M, Abe T, Takahashi N, Nakayama M (2021) Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease. Heliyon 7(2):e06221. https://doi.org/10.1016/j.heliyon.2021.e06221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lin YT, Wu PH, Tsai YC, Hsu YL, Wang HY, Kuo MC, Kuo PL, Hwang SJ (2019) Indoxyl sulfate induces apoptosis through oxidative stress and mitogen-activated protein kinase signaling pathway inhibition in human astrocytes. J Clin Med 8(2):191. https://doi.org/10.3390/jcm8020191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yeh YC, Huang MF, Liang SS, Hwang SJ, Tsai JC, Liu TL, Wu PH, Yang YH, Kuo KC, Kuo MC, Chen CS (2016) Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology 53:148–152. https://doi.org/10.1016/j.neuro.2016.01.006

    Article  CAS  PubMed  Google Scholar 

  20. Lin YT, Wu PH, Lee HH, Mubanga M, Chen CS, Kuo MC, Chiu YW, Kuo PL, Hwang SJ (2019) Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis. Neurotoxicology 73:85–91. https://doi.org/10.1016/j.neuro.2019.02.019

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research received no external funding.

Author information

Authors and Affiliations

  1. Hemodialysis Unit, Division of Nephrology, Università Cattolica del Sacro Cuore, 00168, Rome, Italy

    Maurizio Bossola

  2. Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168, Rome, Italy

    Maurizio Bossola

  3. Laboratory of Experimental Neurophysiology, IRCCS San Raffaele, 00166, Rome, Italy

    Barbara Picconi

  4. Telematic University San Raffaele, 00166, Rome, Italy

    Barbara Picconi

Authors
  1. Maurizio Bossola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Picconi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, M.B. and B.P; writing original draft preparation, M.B., B.P.; writing and editing, B.P., M.B. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Maurizio Bossola.

Ethics declarations

Conflict of interest

None.

Ethical approval

Not applicable.

Human and animal rights

Not applicable.

Informed consent to participate

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bossola, M., Picconi, B. Uremic toxins and the brain in chronic kidney disease. J Nephrol (2024). https://doi.org/10.1007/s40620-024-01929-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40620-024-01929-4

Keywords

Search

Navigation